Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds
|
|
ISIN: LU2234857741
Nettoinventarwert (NAV)
| 115,23 USD | USD | % |
|---|
| Vortag | USD | Datum | 30.09.2025 |
Anlagepolitik
So investiert der Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds: The investment objective of the Sub-Fund is to generate long-term returns consistent with the preservation of capital and prudent investment management. The objective is pursued through a strategy focused on investments in the global healthcare, pharmaceutical and biotechnology sectors or industries. The Sub-Fund will mainly invest in exchange-traded and OTC equity-linked derivatives including but not limited to options, warrants and structured notes. The Sub-Fund may also invest in equities.
Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds aktueller Kurs
| 108,89 USD | 3,89 USD | 3,70 % |
|---|
| Datum | 31.07.2025 |
| Vortag | 108,89 USD |
| Börse | FII |
Rating für Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds
| €uro FondsNote | - |
Fonds Performance: Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds
| Performance 1 Jahr | -11,74 | |
| Performance 2 Jahre | -17,02 | |
| Performance 3 Jahre | -10,07 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
Fundamentaldaten
| WKN | |
| ISIN | LU2234857741 |
| Name | Ruthenium Fd SA SIF - Global Pharma Fund R USD Acc Fonds |
| Fondsgesellschaft | Funds Avenue |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 30.09.2020 |
| Kategorie | Branchen: Gesundheitswesen |
| Währung | USD |
| Volumen | 47 501 156,96 |
| Depotbank | CACEIS Bank, Luxembourg Branch |
| Zahlstelle | |
| Fondsmanager | |
| Geschäftsjahresende | 31.12. |
| Berichtsstand | 06.10.2025 |
Konditionen
| Ausgabeaufschlag | % |
| Verwaltungsgebühr | % |
| Depotbankgebühr | % |
| VL-fähig? | Nein |
| Mindestanlage | |
| Ausschüttung | Thesaurierend |